Citigroup
ANIP icon

Citigroup’s ANI Pharmaceuticals ANIP Stock Holding History

Citigroup’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200
Closed -$6K – 6220
2020
Q4 		$6K Sell
200
-400
-67% -$11.5K ﹤0.01% 7067
2020
Q3 		$17K Buy
600
+400
+200% +$11.9K ﹤0.01% 6287
2020
Q2 		$6K Sell
200
-1,500
-88% -$53.8K ﹤0.01% 7206
2020
Q1 		$69K Hold
1,700
– – ﹤0.01% 5666
2019
Q4 		$105K Buy
1,700
+1,400
+467% +$92.7K ﹤0.01% 5733
2019
Q3 		$22K Sell
300
-200
-40% -$15K ﹤0.01% 6668
2019
Q2 		$41K Buy
500
+400
+400% +$28.4K ﹤0.01% 6640
2019
Q1 		$7K Sell
100
-4,000
-98% -$235K ﹤0.01% 7329
2018
Q4 		$185K Sell
4,100
-200
-5% -$10.5K ﹤0.01% 5091
2018
Q3 		$243K Buy
4,300
+4,200
+4,200% +$257K ﹤0.01% 5044
2018
Q2 		$7K Buy
+100
New +$6.24K ﹤0.01% 7264
2018
Q1 		– Sell
-4,200
Closed -$271K – 7520
2017
Q4 		$271K Buy
4,200
+2,200
+110% +$137K ﹤0.01% 4756
2017
Q3 		$105K Sell
2,000
-2,000
-50% -$95.4K ﹤0.01% 5526
2017
Q2 		$187K Sell
4,000
-4,700
-54% -$227K ﹤0.01% 4855
2017
Q1 		$431K Buy
8,700
+2,000
+30% +$112K ﹤0.01% 3999
2016
Q4 		$406K Buy
6,700
+5,800
+644% +$355K ﹤0.01% 4597
2016
Q3 		$60K Buy
+900
New +$56.3K ﹤0.01% 5542

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup's ANIP Position: Q2 2026 in Review

Citigroup reduced its ANI Pharmaceuticals (ANIP) stake by 5.5% in Q2 2026, selling an estimated $631K and leaving 136,411 shares worth $11.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1515.

Citigroup first reported a position in ANIP in Q2 2013 and has held it in 50 quarters since. The position peaked at $13.6M in Q4 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Citigroup held 136,411 shares of ANI Pharmaceuticals worth $11.3M as of Q2 2026.
  • Citigroup sold 7,870 ANI Pharmaceuticals shares in Q2 2026, an estimated $631K.
  • ANI Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1515 holding.
  • Citigroup first reported a position in ANI Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
  • Citigroup's ANI Pharmaceuticals position peaked at $13.6M in Q4 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.